Dr. Chew and Dr. Bhojani on sepsis risk post ureteroscopy

Video

“What we found from that was the sepsis rate was about 5%... Putting that in perspective, it's about 1 out of every 20 patients that will get this complication,” says Dr. Chew.

In this interview, Naeem Bhojani, MD, FRCSC, and Dr. Ben H. Chew, MD, MSc, FRCSC, discuss the notable findings from their recent studies, “Inpatient, ICU admissions & readmissions associated with sepsis post ureteroscopy among a US-based commercial population” and “Yearly trends in sepsis and mortality after ureteroscopy.” Bhojani is a clinical researcher and associate professor in the division of urological surgery at the University of Montreal, and Chew is an associate professor in the department of urological sciences at the University of British Columbia and a scientist at the Stone Centre at Vancouver General Hospital.

Recent Videos
Video 2 - "Exploring Treatments for BCG-Unresponsive Intermediate-High Risk NMIBC"
Video 1 "Unmet Needs & Standard of Care for Intermediate-High Risk NMIBC"
Video 4 - "The Role of a Multidisciplinary Team in Managing Kidney Cancer"
Video 2 - "Diagnostic Tests for Kidney Cancer"
Video 1 - "A Growing Incidence of Renal Masses"
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
© 2024 MJH Life Sciences

All rights reserved.